Tweed Inc, a wholly owned subsidiary of Canopy Growth Corp. (TSXV:CGC), announced that it has renewed its license to produce and sell marijuana under Health Canada’s Marihuana for Medical Purposes Regulations (MMPR).
As quoted in the press release:
The renewed license, which is valid for 14 months until January 19, 2017, allows Tweed to produce and sell up to 3,500 kg of dried marijuana. In addition, Health Canada has renewed Tweed’s supplemental license to produce fresh marijuana and/or cannabis oil, over the same period.
Bruce Linton, chairman and CEO of Canopy Growth, commented:
This is an indication that Health Canada has confidence in Tweed’s ability to continue to meet the rigorous production, product quality, and security requirements of the regulatory regime. Producing cannabis of this level of quality on a large scale, ensuring it is delivered strictly to the designated registered patient, and ensuring the customer care experience is consistently exceptional, requires a high degree of expertise across multiple functional areas. Tweed continues to prove that we are unsurpassed in these capabilities.